Solid dispersion development to enhance solubility and oral bioavailability for rodent toxicology studies

Aurigene solution: Assessment of biopharmaceutical properties indicated solubility limited oral absorption. Hence, two approaches solid dispersion and nanosuspension were evaluated to enhance oral bioavailability. API was crystalline and showed significant increase in solubility on ionization. These two physicochemical properties were used for solid dispersion formulation development. Solid dispersion and reconstitution vehicle was developed to result in enhance soluble content with minimum precipitation at intestinal pH. Nanosuspension was prepared by ‘top down technology’ using bead mill. Outcome: Dose depended target systemic exposures were obtained by enhancing solubility through in situ salt and amorphization using solid dispersion approach Highlights: Target systemic exposure was achieved with developed solid dispersion based solution formulation Dose dependent increase was observed Due to increase in oral bioavailability, required highest toxicology dose got lowered which hugely reduced API requirement for 90 days GLP toxicology studies.